Wenbin Wei
Impact in
- Oncology top 2%
- Viral-associated cancers and disorders
- Cancer Research top 2%
- Cancer-related molecular mechanisms research
Papers in
-
- Lymphoma Diagnosis and Treatment 17
- Oncology 38
- Viral-associated cancers and disorders 21
- Co-authors
- Lawrence S. YoungPaul G. MurrayKeith LindseyMartina VockerodtDouglas G. WardJennifer F. ToppingPhilip J. JohnsonKarl R. N. Baumforth
- Journals
- British Journal of Cancer (11 papers)The Journal of Pathology (10 papers)Blood (9 papers)Scientific Reports (5 papers)Cancers (4 papers)
- Partner nations
- United KingdomChinaUnited States
In The Last Decade
Wenbin Wei
130 papers receiving 4.5k citations
Peers
Comparison fields: 5 of 134
- Oncology 1.5k
- Cancer Research 714
- Pathology and Forensic Medicine 678
- Immunology 767
- Molecular Biology 2.3k
Countries citing papers authored by Wenbin Wei
This map shows the geographic impact of Wenbin Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenbin Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenbin Wei more than expected).
Fields of papers citing papers by Wenbin Wei
This network shows the impact of papers produced by Wenbin Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenbin Wei. The network helps show where Wenbin Wei may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Wenbin Wei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 1 | |
| 4 | 2024 | 5 | |
| 5 | 2024 | 4 | |
| 6 | 2022 | 7 | |
| 7 | 2022 | 4 | |
| 8 | 2022 | 9 | |
| 9 | 2020 | 19 | |
| 10 | 2019 | 7 | |
| 11 | 2019 | 43 | |
| 12 | 2018 | 34 | |
| 13 | 2016 | 59 | |
| 14 | 2015 | 11 | |
| 15 | 2014 | 19 | |
| 16 | mGluR3 promotes proliferation of human embryonic cortical neural progenitor cells by activating ERK1/2 and JNK2 signaling pathway in vitro. | 2014 | 8 |
| 17 | Gene expression and protein array studies of folliculin-regulated pathways. | 2012 | 5 |
| 18 | 2011 | 15 | |
| 19 | Thoughts on the Development of the Cultural Industry | 2009 | 0 |
| 20 | 2007 | 14 |
About Wenbin Wei
Wenbin Wei is a scholar working on Pathology and Forensic Medicine, Oncology, Immunology, Molecular Biology and Spectroscopy, having authored 134 papers that have together received 4.5k indexed citations. Recurring topics across this work include Viral-associated cancers and disorders (21 papers), Lymphoma Diagnosis and Treatment (17 papers), Immune Cell Function and Interaction (15 papers), Advanced Proteomics Techniques and Applications (12 papers), Epigenetics and DNA Methylation (12 papers), Cancer-related gene regulation (8 papers), RNA modifications and cancer (6 papers) and Bladder and Urothelial Cancer Treatments (6 papers). The work is most often cited by research in Oncology (1.5k citations), Cancer Research (714 citations), Pathology and Forensic Medicine (678 citations), Immunology (767 citations) and Molecular Biology (2.3k citations). Wenbin Wei has collaborated with scholars based in United Kingdom, China and United States. Frequent co-authors include Lawrence S. Young, Paul G. Murray, Keith Lindsey, Martina Vockerodt, Douglas G. Ward, Jennifer F. Topping, Philip J. Johnson, Karl R. N. Baumforth, Lee Fah Yap and William O. Dawson. Their work appears in journals such as British Journal of Cancer, The Journal of Pathology, Blood, Scientific Reports and Cancers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.